International legal regulation on compulsory licensing of patented pharmaceutical products

Student: Rakhimzyanova Renata

Educational Programme: Law of International Trade, Finance and Economic Integration (Master)

Final Grade: 9

Year of Graduation: 2019

This paper analyses the current international legal trends in the development of the institution of compulsory licenses for pharmaceutical products, as well as the directions of the application of main international principles by different states and the consequences of such an application. The main focus is on the provisions of the TRIPS Agreement, the Doha Declaration, the legislation and legal cases of the five states under consideration. In addition, the paper analyses the ambiguous aspects of compulsory licensing - its impact on innovation and investment in R & D and the impact of TRIPS-plus Agreements on it.

Full text (added May 30, 2019)

Student Theses at HSE must be completed in accordance with the University Rules and regulations specified by each educational programme.

Summaries of all theses must be published and made freely available on the HSE website.

The full text of a thesis can be published in open access on the HSE website only if the authoring student (copyright holder) agrees, or, if the thesis was written by a team of students, if all the co-authors (copyright holders) agree. After a thesis is published on the HSE website, it obtains the status of an online publication.

Student theses are objects of copyright and their use is subject to limitations in accordance with the Russian Federation’s law on intellectual property.

In the event that a thesis is quoted or otherwise used, reference to the author’s name and the source of quotation is required.

Search all student theses